A man, 44, has reportedly been admitted to a Melbourne hospital after developing blood clots days after receiving the AstraZeneca Covid-19 vaccine.
The man was vaccinated on March 22 and is now being treated at Box Hill Hospital for low platelets and thrombosis, the ABC has reported.
The Australian said he presented suffering fever and abdominal pain.
Last month, the Therapeutic Goods Administration (TGA) said there is no proven link between blood clots and the vaccine.
“Safety data collected on the COVID-19 vaccines used in Australia is consistent with the known side effects,” the TGA said on its website on April 1.
“We continue to investigate the issue of rare blood clot disorders following the AstraZeneca COVID-19 vaccine in response to reports in Europe.
“A link between vaccination and these events has not been proven.”
Some countries are restricting use of the AstraZeneca vaccine while others have resumed inoculations, as investigations into reports of rare and sometimes severe, blood clots continue.
UK records 30 cases of rare blood clots
British regulators say they have identified 30 cases of rare blood clot events after the use of the AstraZeneca vaccine, 25 more than previously reported.
The Medicines and Healthcare products Regulatory Agency said on Thursday it had received no such reports of clotting events following use of the vaccine made by BioNTech SE and Pfizer.
The health officials said they still believe the benefits of the vaccine in the prevention of Covid-19 far outweigh any possible risk of blood clots.
On March 18, the UK medicines regulator said there had been five cases of a rare brain blood clot among 11 million administered shots.
On Thursday, it put the count at 22 reports of cerebral venous sinus thrombosis, an extremely rare brain clotting ailment, and 8 of other clotting events associated with low blood platelets from a total of 18.1 million doses.
Yahoo News Australia has contacted Box Hill Hospital and the Department of Health and Human Services.
Do you have a story tip? Email: email@example.com